in 2021 found that the prognosis of glioblastoma (GBM) can be determined by seven differentially expressed genes (DEGs) 47, namely CLEC5A, HOXC6, HOXA5, CCL2, GPRASP1, BSCL2, and PTX3. The gene discussed is HOXC6; the disease is glioblastoma.